CVE-2023-52333

Allegra saveFile Directory Traversal Remote Code Execution Vulnerability

Description

Allegra saveFile Directory Traversal Remote Code Execution Vulnerability. This vulnerability allows remote attackers to execute arbitrary code on affected installations of Allegra. Although authentication is required to exploit this vulnerability, product implements a registration mechanism that can be used to create a user with a sufficient privilege level. The specific flaw exists within the saveFile method. The issue results from the lack of proper validation of a user-supplied path prior to using it in file operations. An attacker can leverage this vulnerability to execute code in the context of LOCAL SERVICE. Was ZDI-CAN-22548.

Category

7.3
CVSS
Severity: High
CVSS 3.1 •
CVSS 3.0 •
EPSS 0.71% Top 30%
Vendor Advisory trackplus.com
Affected: Allegra Allegra
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2023-52333?
CVE-2023-52333 has been scored as a high severity vulnerability.
How to fix CVE-2023-52333?
To fix CVE-2023-52333, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-52333 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-52333 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-52333?
CVE-2023-52333 affects Allegra Allegra.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.